Document is current
Any future updates will be listed below
-
Authors
García-Giménez, José Luis https://orcid.org/0000-0001-7547-7872
García-López, Eva
Mena-Mollá, Salvador
Beltrán-García, Jesús
Osca-Verdegal, Rebeca
Nacher-Sendra, Elena
Aguado-Velasco, Carmen
Casabó-Vallés, Germán
Romá-Mateo, Carlos
Rodriguez-Gimillo, María
Antúnez, Oreto
Ferreres, José
Pallardó, Federico V.
Carbonell, Nieves
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI16/01036, PI19/00994, DTS21/00193, DTS17/00132, IFI18/00015, FI20/00202)
Agència Valenciana de la Innovació (INNVA1/2020/85)
Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (CIAPOT/2021/15)
Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona (CI18-0009)
FIPSE (3819-21)
- License Information
-
More Information
Article History
Received: 21 October 2022
Accepted: 14 May 2023
First Online: 23 May 2023
Declarations
:
: Informed consent was obtained from all subjects involved in the study; all the experimental protocols and methods were carried out after obtaining approval from the local Biomedical Research Ethics Committee of HCUV and performed following the relevant guidelines and regulations in accordance with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects. Samples and data from patients included in this study were provided by the INCLIVA Biobank with the appropriate approval of the Ethical and Scientific Committees.
: “Not applicable”.
: JLG-G, CR-M and FVP are inventors of a patent (EP3535587B1) related with the detection of circulating histones by mass spectrometry. JLG-G, SM-M and FVP are funders and own stocks of EpiDisease S.L., a spin-off from the Consortium Center for Biomedical Network Research (CIBER-ISCIII) and INCLIVA Biomedical Research Institute. Other authors declare no competing interest.
